title: Protective effect of pregnancy for development of uterine leiomyoma.
abstract: Many factors that can modulate the risk of developing uterine leiomyoma have been identified, including parity. Epidemiological data on decreased risk of developing this disease has been subject to different interpretations regarding whether pregnancy per se is protective or, as leiomyomas are a major cause of infertility, women that develop these tumors are less fertile and thus have lower pregnancy rates. We have utilized an animal model genetically predisposed to uterine leiomyoma to investigate the potential protective effect of pregnancy on the risk of developing this disease. Female Eker rats that carry a mutation in the tuberous sclerosis 2 (Tsc-2) tumor suppressor gene develop uterine leiomyoma with a frequency of 65% when nulliparous. These animals were bred with intact or vasectomized males and tumor incidence determined after a single pregnancy (to confirm fertility) or multiple pregnancies over the lifetime of the animals. Females with multiple litters displayed a dramatic shift in tumor incidence and presentation. Tumor incidence decreased from 71% in single litter females to 10% in females that had multiple litters (average: five litters/animal). Interestingly, females bred with vasectomized males also exhibited a reduced tumor incidence of 41%, suggesting that the hormonal changes associated with early stages of pregnancy that occur in pseudopregnant females may have contributed to the protective effect of pregnancy.
authors.affiliation: UT MD Anderson Cancer Center, Science Park Research Division, Park Road 1C, Smithville, TX 78957, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Walker
authors.forename: K
authors.initials: K
authors.lastname: Cesen-Cummings
authors.forename: C
authors.initials: C
authors.lastname: Houle
authors.forename: D
authors.initials: D
authors.lastname: Baird
authors.forename: J C
authors.initials: JC
authors.lastname: Barrett
authors.forename: B
authors.initials: B
authors.lastname: Davis
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D005260:Female; D005298:Fertility / Q000235:genetics; D020022:Genetic Predisposition to Disease; D015994:Incidence; D007889:Leiomyoma / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D009154:Mutation; D010298:Parity / Q000502:physiology*; D011247:Pregnancy; D011272:Pregnancy, Multiple; D011555:Pseudopregnancy; D051381:Rats; D012097:Repressor Proteins / Q000235:genetics; D012307:Risk Factors; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; D014594:Uterine Neoplasms / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D014659:Vasectomy
chemical_list: D012097:Repressor Proteins; C000624655:Tsc2 protein, rat; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins